RxDoctor Payments Data

Trevor Schmitz, MD

Orthopaedic Surgery of the Spine · Des Moines, IANPI 1326364449

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,498 of the $5,632 with a category attached, or 62.1%. Medtronic accounts for 68.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $2,586 and has fallen 88.9% since, to $287 in 2025.

$5,632in general payments, 2019–2025

Across 132 payments — averaging $42.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Johnson & Johnson$898
  • Stryker$247
  • DJO, LLC$147
  • Biocomposites Inc$121
  • Centinel Spine, LLC$121
  • plus $231 from 4 others

What the payments were for

  • Consulting fees$1,51327%
  • Travel & lodging$62211%
  • Food & beverage$3,49862%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)113$3,866
Johnson & Johnson9$898
Stryker2$247
DJO, LLC1$147
Biocomposites Inc1$121
Centinel Spine, LLC1$121
Smaio USA Corporation1$105
Lifenet Health1$79
Orthofix Medical, Inc.2$29
Pacira Pharmaceuticals Incorporated1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$576,758
Medicare patients
738
Services billed
3,962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl83$346
Gabapentin49$257
Methylprednisolone32$236
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$80
Meloxicam27$54

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →